Neurosense Therapeutics Ltd Stock Momentum Indicators Aroon
| NRSNW Stock | USD 0.15 0.11 42.31% |
| Symbol |
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Aroon Indicator was developed by Tushar S. Chande to indicate when a new trend is dawning. The indicator consists of two lines that measure how long it has been since the highest high/lowest low has occurred within an (N) period range. When NeuroSense Therapeutics Aroon Up is staying between 70 and 100 then it indicates an upward trend. When the Aroon Down is staying between 70 and 100 then it indicates an downward trend. A strong upward trend is indicated when the Aroon Up is above 70 while the Aroon Down is below 30. When NeuroSense Therapeutics Aroon Down crosses above the Aroon Up, it indicates a weakening of the upward trend (and vice versa).
NeuroSense Therapeutics Technical Analysis Modules
Most technical analysis of NeuroSense Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NeuroSense from various momentum indicators to cycle indicators. When you analyze NeuroSense charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About NeuroSense Therapeutics Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NeuroSense Therapeutics Ltd. We use our internally-developed statistical techniques to arrive at the intrinsic value of NeuroSense Therapeutics Ltd based on widely used predictive technical indicators. In general, we focus on analyzing NeuroSense Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NeuroSense Therapeutics's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of NeuroSense Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for NeuroSense Therapeutics, we also check how macroeconomic factors affect NeuroSense Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2021 | 2023 | 2024 (projected) | Current Ratio | 19.12 | 0.84 | 0.8 | Net Debt To EBITDA | 3.2 | 0.23 | 0.22 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NeuroSense Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NeuroSense Therapeutics' short interest history, or implied volatility extrapolated from NeuroSense Therapeutics options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 90 shares | |
 | Baby Boomer Prospects Invested over 40 shares | |
 | Banking Invested over 40 shares | |
 | Driverless Cars Invested few shares | |
 | Chemicals Invested over 30 shares | |
 | Hedge Favorites Invested over 100 shares | |
 | Momentum Invested over 50 shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Social Domain Invested few shares | |
 | Impulse Invested over 100 shares | |
 | ESG Investing Invested few shares | |
 | FinTech Invested over 40 shares |
Additional Tools for NeuroSense Stock Analysis
When running NeuroSense Therapeutics' price analysis, check to measure NeuroSense Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroSense Therapeutics is operating at the current time. Most of NeuroSense Therapeutics' value examination focuses on studying past and present price action to predict the probability of NeuroSense Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroSense Therapeutics' price. Additionally, you may evaluate how the addition of NeuroSense Therapeutics to your portfolios can decrease your overall portfolio volatility.